Hepatitis C Treatment Options - New Data Shows Telbivudine Provided Significantly Greater Response Compared to Lamivudine in the Treatment of Chinese

New Data Shows Telbivudine Provided Significantly Greater Response Compared to Lamivudine in the Treatment of Chinese
[Press Release] PR Newswire via Yahoo! Finance - Mar 27 5:30 AM
Idenix Pharmaceuticals, Inc. and Novartis today announced new data that demonstrate telbivudine, an investigational oral, once-daily nucleoside analogue, provided significantly greater antiviral and clinical efficacy in Chinese patients with chronic hepatitis B after one-year of treatment when compared with a current standard of care, lamivudine.Save to My Web

euro adhoc: Intercell AG / Financial Figures/Balance Sheet / Intercell announces preliminary 2005 full year results:
Presseportal - Mar 05 10:29 PM
06.03.2006 Intercell announces preliminary 2005 full year results: Good progress in product development - significant increase in revenues - strong cash ...Save to My Web